Arbiter Partners Capital Management Increased By $3.84 Million Its Sportsman’s Warehouse Holdin (SPWH) Position; Epizyme (EPZM)’s Sentiment Is 1.93

October 13, 2017 - By Hazel Jackson

Arbiter Partners Capital Management Llc increased Sportsman’s Warehouse Holdin (SPWH) stake by 53.42% reported in 2017Q2 SEC filing. Arbiter Partners Capital Management Llc acquired 768,758 shares as Sportsman’s Warehouse Holdin (SPWH)’s stock rose 8.37%. The Arbiter Partners Capital Management Llc holds 2.21M shares with $11.92M value, up from 1.44M last quarter. Sportsman’s Warehouse Holdin now has $183.94 million valuation. The stock rose 0.47% or $0.02 reaching $4.32 per share. About 294,301 shares traded. Sportsman’s Warehouse Holdings Inc (NASDAQ:SPWH) has declined 41.90% since October 13, 2016 and is downtrending. It has underperformed by 58.60% the S&P500.

Epizyme, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $1.19 billion. The Firm discovers, develops and plans to commercialize epigenetic therapies for cancer patients. It currently has negative earnings. The Firm is engaged in the discovery and development of novel epigenetic therapies for cancer patients.

About 209,153 shares traded. Epizyme Inc (EPZM) has risen 91.85% since October 13, 2016 and is uptrending. It has outperformed by 75.15% the S&P500.

Foresite Capital Management Ii Llc holds 10.27% of its portfolio in Epizyme Inc for 1.48 million shares. Palo Alto Investors Llc owns 5.70 million shares or 4.02% of their US portfolio. Moreover, Nea Management Company Llc has 3.44% invested in the company for 6.26 million shares. The Maryland-based Rock Springs Capital Management Lp has invested 0.9% in the stock. Oracle Investment Management Inc, a Connecticut-based fund reported 292,380 shares.

Since January 1, 0001, it had 0 buys, and 3 sales for $362,502 activity.

Analysts await Epizyme Inc (NASDAQ:EPZM) to report earnings on November, 2. They expect $-0.66 EPS, down 57.14% or $0.24 from last year’s $-0.42 per share. After $-0.48 actual EPS reported by Epizyme Inc for the previous quarter, Wall Street now forecasts 37.50% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com